PVMCV
Polaris Venture Management Co V Portfolio holdings
AUM
$14.1M
This Quarter Return
+15.57%
1 Year Return
+121.41%
3 Year Return
+278.88%
5 Year Return
+1,121.38%
10 Year Return
–
AUM
$200M
AUM Growth
+$200M
(+8.9%)
Cap. Flow
-$2.09M
Cap. Flow
% of AUM
-1.05%
Top 10 Holdings %
Top 10 Hldgs %
99.17%
Holding
12
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
Cardlytics
CDLX
|
$2.09M |
Sector Composition
| 1 | Healthcare | 61.13% |
| 2 | Communication Services | 32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Cardlytics
CDLX
$54.3M
| $63.9M | 32% |
2,552,626
-83,636
| -3% | -$2.09M |
|
2
Fate Therapeutics
FATE
$120M
| $40.3M | 20.17% |
2,473,186
| – | – |
|
3
Neuronetics
STIM
$220M
| $26.4M | 13.24% |
824,765
| – | – |
|
4
Cartesian Therapeutics
RNAC
$261M
| $25M | 12.51% |
1,606,813
| – | – |
|
5
KALA BIO
KALA
$78.8M
| $18.3M | 9.18% |
1,857,582
| – | – |
|
|
TTOO
6
DELISTED
T2 Biosystems, Inc
TTOO
| $13.7M | 6.87% |
1,841,924
| – | – |
|
|
TRVN
7
DELISTED
Trevena, Inc.
TRVN
| $4.35M | 2.18% |
2,053,540
| – | – |
|
8
X4 Pharmaceuticals
XFOR
$84.2M
| $3.03M | 1.52% |
1,868,957
| – | – |
|
|
GNCA
9
DELISTED
Genocea Biosciences, Inc.
GNCA
| $1.54M | 0.77% |
1,968,606
| – | – |
|
|
ATYR
10
aTyr Pharma
ATYR
$527M
| $1.49M | 0.74% |
1,827,992
| – | – |
|
11
Pulmatrix
PULM
$18M
| $1.33M | 0.67% |
3,594,381
| – | – |
|
12
Dare Bioscience
DARE
$27.2M
| $318K | 0.16% |
326,243
| – | – |
|